Die Schweizer Firma Genoma wirbt mit dem Bild eines Mädchens mit Down-Syndrom für einen Pränatal-Test auf Trisomie 21. Inzwischen findet sie, „es war ein Fehler“. Doch das Produkt selbst hat gravierende Folgen und ist auch in Deutschland zugelassen. Von Katja Tichomirowa
You need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from Turnstile to submit the form. Please note that doing so will share data with third-party providers.
More Information